Anterogen.Co.Ltd Total Liabilities

Latest as of September 2025: ₩1.40 Billion KRW ≈ $951.49K USD

Anterogen.Co.Ltd total liabilities. Based on the latest financial reports, Anterogen.Co.Ltd (065660) has total liabilities worth ₩1.40 Billion KRW (≈ $951.49K USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Anterogen.Co.Ltd to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Anterogen.Co.Ltd (2014–2024)

Total liabilities of Anterogen.Co.Ltd from 2014 to 2024. This chart illustrates how Anterogen.Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore investment intensity of Anterogen.Co.Ltd to see how much of total assets are deployed in long-term investments.

Anterogen.Co.Ltd Competitors by Total Liabilities

The table below lists competitors of Anterogen.Co.Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Pioneer Credit Ltd AU:PNC	Australia	AU$325.86 Million
EverFocus Electronics Corp TW:5484	Taiwan	NT$344.51 Million
Nutriband Inc NASDAQ:NTRB	USA	$964.36K
Real Estate & E-Commerce Split Corp TO:RS	Canada	CA$117.81 Million
AGFA Gevaert NV BR:AGFB	Belgium	€1.00 Billion
Aniplus Inc KQ:310200	Korea	₩143.19 Billion
DEVEX Resources Ltd AU:DEV	Australia	AU$2.79 Million
Tan Chong Motor Holdings Bhd KLSE:4405	Malaysia	RM2.21 Billion

Liability Composition Analysis (2014–2024)

This chart breaks down Anterogen.Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Anterogen.Co.Ltd's balance sheet.

Liquidity & Leverage Metrics

Anterogen.Co.Ltd Total Liabilities Ratios Explained

Anterogen.Co.Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	41.75	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.02	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.02	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Anterogen.Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Anterogen.Co.Ltd (2014–2024)

The table below shows the annual total liabilities of Anterogen.Co.Ltd from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩5.87 Billion ≈ $3.98 Million	-70.65%
2023-12-31	₩19.99 Billion ≈ $13.54 Million	+15.25%
2022-12-31	₩17.34 Billion ≈ $11.75 Million	-12.57%
2021-12-31	₩19.83 Billion ≈ $13.44 Million	+50.98%
2020-12-31	₩13.14 Billion ≈ $8.90 Million	-18.91%
2019-12-31	₩16.20 Billion ≈ $10.98 Million	-64.29%
2018-12-31	₩45.37 Billion ≈ $30.75 Million	+293.48%
2017-12-31	₩11.53 Billion ≈ $7.81 Million	+721.17%
2016-12-31	₩1.40 Billion ≈ $951.53K	-24.04%
2015-12-31	₩1.85 Billion ≈ $1.25 Million	+22.79%
2014-12-31	₩1.51 Billion ≈ $1.02 Million	--

About Anterogen.Co.Ltd

KQ:065660 Korea Pharmaceuticals

Market Cap

$70.45 Million

₩103.95 Billion KRW

Market Cap Rank

#20375 Global

#1108 in Korea

Share Price

₩13070.00

Change (1 day)

-3.61%

52-Week Range

₩13070.00 - ₩58000.00

All Time High

₩197700.00